These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7747455)

  • 21. Functional relationship between the matrix proteins of feline and simian immunodeficiency viruses.
    Manrique ML; González SA; Affranchino JL
    Virology; 2004 Nov; 329(1):157-67. PubMed ID: 15476883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo homodimerisation of HTLV-1 Gag and MA gives clues to the retroviral capsid and TM envelope protein arrangement.
    Rayne F; Kajava AV; Lalanne J; Mamoun RZ
    J Mol Biol; 2004 Oct; 343(4):903-16. PubMed ID: 15476809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
    Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
    Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
    Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.
    Morikawa Y; Goto T; Yasuoka D; Momose F; Matano T
    J Virol; 2007 Sep; 81(18):9911-21. PubMed ID: 17609278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a human immunodeficiency virus type 1 gag mutant with an engineered 110-amino-acid insertion in the matrix protein domain.
    Wang CT; Yang AH; Chiang CC
    J Med Virol; 2000 Aug; 61(4):423-32. PubMed ID: 10897059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
    Wang CT; Zhang Y; McDermott J; Barklis E
    J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    Spearman P; Wang JJ; Vander Heyden N; Ratner L
    J Virol; 1994 May; 68(5):3232-42. PubMed ID: 8151785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.
    Wang CT; Barklis E
    J Virol; 1993 Jul; 67(7):4264-73. PubMed ID: 7685414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation.
    Jørgensen EC; Pedersen FS; Jørgensen P
    J Virol; 1992 Jul; 66(7):4479-87. PubMed ID: 1318415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
    Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
    J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
    Ono A; Freed EO
    J Virol; 1999 May; 73(5):4136-44. PubMed ID: 10196310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
    J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
    Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
    J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.
    Pal R; Reitz MS; Tschachler E; Gallo RC; Sarngadharan MG; Veronese FD
    AIDS Res Hum Retroviruses; 1990 Jun; 6(6):721-30. PubMed ID: 2194551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myristate exposure in the human immunodeficiency virus type 1 matrix protein is modulated by pH.
    Fledderman EL; Fujii K; Ghanam RH; Waki K; Prevelige PE; Freed EO; Saad JS
    Biochemistry; 2010 Nov; 49(44):9551-62. PubMed ID: 20886905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
    Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
    J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Gag mutation and processing on retroviral dimeric RNA maturation.
    Fu W; Dang Q; Nagashima K; Freed EO; Pathak VK; Hu WS
    J Virol; 2006 Feb; 80(3):1242-9. PubMed ID: 16415001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.